RSB Spine's InterPlateâ„¢ Vertebral Body Replacement Implant System, Granted Conditional USFDA 510(k) Approval

Filed in archive Diagnostics , Treatment on August 31, 2006

A private medical device company focused on developing innovative spinal implants, RSB Spine, LLC has been recently granted conditional approval by the USFDA for the company's 510(k) application that would permit marketing of the InterPlateâ„¢ Vertebral Body Replacement System.

Spinal fusion is one of the most common spinal procedures performed by neurosurgeons and orthopedic spine surgeons.

The InterPlateâ„¢ Vertebral Body Replacement System is a unique spinal implant designed to rapidly facilitate this process and is used in conjunction with graft material to fuse two or more spinal vertebrae together.

According to Robert S. Bray Jr., M.D., a neurosurgeon who has performed over 7,500 spine surgeries, director of St. Johns Spine Institute in Santa monica, CA, and inventor of the InterPlateâ„¢ said:

"The InterPlateâ„¢ is a next- generation device incorporating the best features of plate and interbody designs without the drawbacks. I believe its innovative design and unique features will appeal to spine surgeons and that it will soon become the implant of choice for single-level spinal fusion."

RSB Spine, LLC executives are confidents that the InterPlateâ„¢ can rapidly become a major revenue generator and change how spinal fusions are viewed, mainly because of the overwhelming positive response from surgeons who have seen the Interplateâ„¢.

Source: PR Newswire